Estrogen Supplementation and Bone Health in Women With CF
Recruiting
Phase 4
Interventional Study
Cystic Fibrosis
Hypoestrogenism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 0 – 100
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 75 (estimated)
- Sponsor
- Johns Hopkins University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to learn about the role of estrogen and other hormones in bone development in adolescent and young adult women with cystic fibrosis (CF). The study has two main components, an observational study and a feasibility sub-study. The main questions it aims to answer are:
* How do different forms of hormonal contraception (e.g. birth control pill or other progesterone only met…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Observational Study:
Inclusion Criteria:
* CF Diagnosis
* Females who have had at least 1 menstrual cycle
* Planning to use same formulation of estrogen supplementation (or none) for duration of study
Exclusion Criteria:
* Use of anti-osteoporosis therapy including anti-resorptives such as bisph…
Contacts